Pergolide protects CA1 neurons from apoptosis in a gerbil model of global cerebral ischemia

Neurological Research

Volumn 30, Issue 1, 2008, Pages 92-98

  Zong, Xue Mei ^a,b   Sun, Ya Feng ^a   Pei, Dong Sheng ^a   Zeng, Yin Ming ^b   Xu, Tie ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

^b Jiangsu Province Key Laboratory of Anesthesiology   (China)

Author keywords

Cerebral ischemia; Dopamine receptor; Pergolide

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DNA NUCLEOTIDYLEXOTRANSFERASE; EOSIN; HEMATOXYLIN; PERGOLIDE; PROTEIN C JUN; SPIPERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY; CONTROLLED STUDY; DRUG EFFECT; FOREBRAIN; GERBIL; HIPPOCAMPUS; MALE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; DOPAMINE AGONISTS; EXPLORATORY BEHAVIOR; GERBILLINAE; HIPPOCAMPUS; IN SITU NICK-END LABELING; MALE; NEURONS; PERGOLIDE; PROTO-ONCOGENE PROTEINS C-JUN; TIME FACTORS;

EID: 44449166053     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164107X228688     Document Type: Article

References (44)

1. Blomqvist P, Lindvall O, Wieloch T. Lesions of the locus coeruleus system aggravate ischemic damage in the rat brain. Neurosci Lett 1985; 58: 353-358
2. Evans MC, Swan JH, Meldrum BS. An adenosine analogue, 2-chloroadenosine, protects against long term development of ischaemic cell loss in the rat hippocampus. Neurosci Lett 1987; 83: 287-292
3. Rothman S. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neurosci 1984; 4: 1884-1891
4. Choi DW. Cerebral hypoxia: Some new approaches and unanswered questions. J Neurosci 1990; 10: 2493-2501
5. Globus MY, Busto R, Dietrich WD, et al. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J Neurochem 1988; 51: 1455-1464
6. Richards DA, Obrenovitch TP, Johonson-Mora A, et al. Effect of global ischaemia, under simulated penumbral conditions, on brain monoamine neurochemistry and subsequent neurological and histological deficits. J Neurochem 1993; 61: 1801-1807
7. Weinberger J, Nieves-Rosa J, Cohen G. Nerve terminal damage in cerebral ischemia: Protective effect of alpha-methyl-para-tyrosine. Stroke 1985; 16: 864- 870
8. Clemens JA, Phebus LA. Dopamine depletion protects striatal neurons from ischemia-induced cell death. Life Sci 1988; 42: 707-713
9. Hashimoto N, Matsumoto T, Mabe H, et al. Dopamine has inhibitory and accelerating effects on ischemia-induced neuronal cell damage in the rat striatum. Brain Res Bull 1994; 33: 281-288
10. Buisson A, Callebert J, Mathieu E, et al. Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia. J Neurochem 1992; 59: 1153-1157
11. Colbourne F, Auer RN, Sutherland GR. Characterization of postischemic behavioral deficits in gerbils with and without hypothermic neuroprotection. Brain Res 1998; 803: 69-78
12. Colbourne F, Corbett D. Delayed postischemic hypothermia: A six month survival study using behavioral and histological assessments of neuroprotection. J Neurosci 1995; 15: 7250-7260
13. Wang D, Corbett D. Cerebral ischemia, locomotor activity and spatial mapping. Brain Res 1990; 533: 78-82
14. Stamford JA, Isaac D, Hicks CAet al. Ascorbic acid is neuroprotective against global ischaemia in striatum but not hippocampus: Histological and voltammetric data. Brain Res 1999; 835: 229-240
15. Masserano JM, Gong L, Kulaga H, et al. Dopamine induces apoptotic cell death of a catecholaminergic cell line derived from the central nervous system. Mol Pharmacol 1996; 50: 1309-1315
16. Luo Y, Umegaki H, Wang X, et al. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J Biol Chem 1998; 273: 3756-3764
17. Maker HS, Weiss C, Brannan TS. Amine-mediated toxicity. The effects of dopamine, norepinephrine, 5-hydroxytryptamine, 6-hydroxydopamine, ascorbate, glutathione and peroxide on the in vitro activities of creatine and adenylate kinase in the brain of the rat. Neuropharmacology 1986; 25: 25-32
18. Stokes AH, Brown BG, Lee CK, et al. Tyrosinase enhances the covalent modification of DNA by dopamine. Brain Res Mol Brain Res 1996; 42: 167-170
19. 2 in vitro. Brain Res 1995; 671: 181-186
20. Kuhn DM, Arthur R. Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: Possible endogenous toxin to serotonin neurons. J Neurosci 1998; 18: 7111-7117
21. Tsukada H, Fukumoto D, Nishiyama S, et al. Transient focal ischemia affects the cAMP second messenger system and coupled dopamine D1 and 5-HT1A receptors in the living monkey brain: A positron emission tomography study using microdialysis. J Cereb Blood Flow Metab 2004; 24: 898-906
22. Cepeda C, Colwell CS, Itri JN, et al. Dopaminergic modulation of early signs of excitotoxicity in visualized rat neostriatal neurons. Eur J Neurosci 1998; 10: 3491-3497
23. Sawada H, Ibi M, Kihara T, et al. Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: Mechanisms of neuroprotective treatment against oxidative stress. Ann Neurol 1998; 44: 110-119
24. Hirata H, Ogawa N, Haba K, et al. Effects of chronic administration of lisuride hydrogen maleate on aromatic amine and metabolite levels in the gerbil brain following bilateral common carotid ligation. Arch Int Pharmacodyn Ther 1992; 315: 5-15
25. Caldwell MA, Reymann JM, Bentue-Ferrer D, et al. The dopamine agonists lisuride and piribedil protect against behavioural and histological changes following 4-vessel occlusion in the rat. Neuropsychobiology 1996; 34: 117-124
26. Caldwell MA, Reymann JM, Allain H, et al. Lisuride prevents learning and memory impairment and attenuates the increase in extracellular dopamine induced by transient global cerebral ischemia in rats. Brain Res 1997; 771: 305-318
27. Nisoli E, Tonello C, Imhof R, et al. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist. J Pharmacol Exp Ther 1993; 266: 97-105
28. Ohta K, Kuno S, Mizuta I, et al. Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. Life Sci 2003; 73: 617-626
29. Wang Y, Chang CF, Morales M, et al. Protective effects of glial cell line-derived neurotrophic factor in ischemic brain injury. Ann NY Acad Sci 2002; 962: 423-437
30. Wang Y, Lin SZ, Chiou AL, et al. Glial cell line-derived neurotrophic factor protects against ischemia-induced injury in the cerebral cortex. J Neurosci 1997; 17: 4341-4348
31. 2. Eur J Pharmacol 2002; 434: 17-20
32. Opacka-Juffry J, Wilson AW, Blunt SB. Effects of pergolide treatment on in vivo hydroxyl free radical formation during infusion of 6-hydroxydopamine in rat striatum. Brain Res 1998; 810: 27-33
33. Thongsaard W, Kendall DA, Bennett GW, et al. A simple method for measuring dopamine release from rat brain slices. J Pharmacol Toxicol Methods 1997; 37: 143-148
34. Nishibayashi S, Asanuma M, Kohno M, et al. Scavenging effects of dopamine agonists on nitric oxide radicals. J Neurochem 1996; 67: 2208-2211
35. Yang C, Lai H, Zhan C, et al. nNOS expression of hippocampal neurons in aged rats after brain ischemia/reperfusion and its role in DND development. Chin J Traumatol 2002; 5: 232-236
36. Elibol B, Soylemezoglu F, Unal I, et al. Nitric oxide is involved in ischemia-induced apoptosis in brain: A study in neuronal nitric oxide synthase null mice. Neuroscience 2001; 105: 79-86
37. Iadecola C, Zhang F, Casey R, et al. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke 1996; 27: 1373-1380
38. O'Neill M, Hicks C, Ward M, et al. Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia. Brain Res 1997; 760: 170-178
39. Glover V, Clow A, Sandler M. Effects of dopaminergic drugs on superoxide dismutase: Implications for senescence. J Neural Transm Suppl 1993; 40: 37-45
40. Clow A, Freestone C, Lewis E, et al. The effect of pergolide and MDL 72974 on rat brain CuZn superoxide dismutase. Neurosci Lett 1993; 164: 41-43
41. Asanuma M, Ogawa N, Nishibayashi S, et al. Protective effects of pergolide on dopamine levels in 6-hydroxydopamine-lesioned mouse brain. Arch Int Pharmacodyn Ther 1995; 329: 221-230
42. Tagaya M, Matsumoto M, Kitagawa K, et al. Recombinant human superoxide dismutase can attenuate ischemic neuronal damage in gerbils. Life Sci 1992; 51: 253-259
43. Wengenack TM, Curran GL, Poduslo JF. Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia. Brain Res 1997; 754: 46-54
44. Jaspers RM, Block F, Heim C, et al. Spatial learning is affected by transient occlusion of common carotid arteries (2VO): Comparison of behavioural and histopathological changes after '2VO' and 'four-vessel- occlusion' in rats. Neurosci Lett 1990; 117: 149-153